Internet Archive Scholar

Variceal Bleeding in Patients with Initation of Sofosbuvir and Ribavirin – Case Reports

Sadiq Memon, Department of Gastroenterology, Asian Institute of Medical Sciences, Hyderabad, Pakistan., Madiha Zaki, Shahzad Ali Jiskani, Department of Gastroenterology, Indus Medical College Hospital, Tando Muhammad Khan, Pakistan., Department of Pathology, Indus Medical College Hospital, Tando Muhammad Khan, Pakistan.
2021 National Journal of Health Sciences  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (243.1 kB)
https://web.archive.org/web/20210716225116/https://njhsciences.com/wp-content/uploads/2021/07/Case-Report-2.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

Abstract: Sofosbuvir is an oral nucleoside analogue and potent inhibitor of the Hepatitis C virus (HCV) RNA polymerase that is used in combination with other antiviral agents to treat chronic Hepatitis C Nevertheless, and for unknown reasons, successful antiviral therapy of Hepatitis C with Sofosbuvir and other direct acting agents in patients with cirrhosis is occasionally complicated by hepatic decompensation. Here we describe 2 case report of upper gi bleed at initial days of treatment with
more » ... ofosbuvir and Ribavirin. Keywords: Variceal bleeding , Sofosdbuvir, Ribavirin, Heptitis C, Nucleoside analogue, Antiviral.
doi:10.21089/njhs.54.0175 fatcat:dqjjpspygzhu3azqzy7snasami
Citation

Sadiq Memon, Department of Gastroenterology, Asian Institute of Medical Sciences, Hyderabad, Pakistan., Madiha Zaki, Shahzad Ali Jiskani, Department of Gastroenterology, Indus Medical College Hospital, Tando Muhammad Khan, Pakistan., Department of Pathology, Indus Medical College Hospital, Tando Muhammad Khan, Pakistan.. "Variceal Bleeding in Patients with Initation of Sofosbuvir and Ribavirin – Case Reports." National Journal of Health Sciences 5.4 (2021) 175-176